These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, randomized, placebo-controlled study. Ascher B; Hoffmann K; Walker P; Lippert S; Wollina U; Havlickova B J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1707-15. PubMed ID: 24605812 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of injectable deoxycholic acid for submental fat reduction: a systematic review and meta-analysis of randomized controlled trials. Cunha KS; Lima F; Cardoso RM Expert Rev Clin Pharmacol; 2021 Mar; 14(3):383-397. PubMed ID: 33523775 [No Abstract] [Full Text] [Related]
6. The Use of Deoxycholic Acid for the Clinical Reduction of Excess Submental Fat in Indian Patients. Shome D; Khare S; Kapoor R J Drugs Dermatol; 2019 Mar; 18(3):266-272. PubMed ID: 30909331 [TBL] [Abstract][Full Text] [Related]
7. ATX-101 (Deoxycholic Acid Injection) for Reduction of Submental Fat: Results From a 12-Month Open-Label Study. Beer K; Weinkle SH; Cox SE; Rubin MG; Shamban A; Somogyif C J Drugs Dermatol; 2019 Sep; 18(9):870-877. PubMed ID: 31524342 [TBL] [Abstract][Full Text] [Related]
8. Improvement in Jowl Fat following ATX-101 Treatment: Results from a Single-Site Study. Shridharani SM Plast Reconstr Surg; 2020 Apr; 145(4):929-935. PubMed ID: 32221205 [TBL] [Abstract][Full Text] [Related]
9. Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III, randomized, placebo-controlled study. Rzany B; Griffiths T; Walker P; Lippert S; McDiarmid J; Havlickova B Br J Dermatol; 2014 Feb; 170(2):445-53. PubMed ID: 24147933 [TBL] [Abstract][Full Text] [Related]
10. REFINE-1, a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial With ATX-101, an Injectable Drug for Submental Fat Reduction. Jones DH; Carruthers J; Joseph JH; Callender VD; Walker P; Lee DR; Subramanian M; Lizzul PF; Gross TM; Beddingfield FC Dermatol Surg; 2016 Jan; 42(1):38-49. PubMed ID: 26673433 [TBL] [Abstract][Full Text] [Related]
11. Safety, Tolerability, and Efficacy of Repeat-Dose Injections of IncobotulinumtoxinA in the Treatment of Upper Facial Lines: Results from a Prospective, Open-Label, Phase III Study. Fischer T; Sattler G; Prager W; Rzany B; Pavicic T; Gauglitz G; Weissenberger P; Riaz S J Drugs Dermatol; 2020 May; 19(5):461-469. PubMed ID: 32484631 [TBL] [Abstract][Full Text] [Related]
12. Clinical Evaluation of Fractional Radiofrequency for the Treatment and Reduction of Wrinkles: A Prospective Study. Kang A; Kilmer S J Drugs Dermatol; 2022 Jan; 21(1):43-48. PubMed ID: 35005858 [TBL] [Abstract][Full Text] [Related]
13. Clinical study to evaluate the performance of a noninvasive focused ultrasound device for thigh fat and circumference reduction compared to control. Wilkerson EC; Bloom BS; Goldberg DJ J Cosmet Dermatol; 2018 Apr; 17(2):157-161. PubMed ID: 29359385 [TBL] [Abstract][Full Text] [Related]
14. Non-Submental Applications of Injectable Deoxycholic Acid: A Systematic Review. Sung CT; Lee A; Choi F; Juhasz M; Mesinkovska NA J Drugs Dermatol; 2019 Jul; 18(7):675-680. PubMed ID: 31334926 [TBL] [Abstract][Full Text] [Related]
15. Safety and Efficacy of Deoxycholic Acid Injection for Hypogastric Fat Reduction: A Pilot Study. Salvador L; Benito-Ruiz J Dermatol Surg; 2021 Apr; 47(4):e132-e137. PubMed ID: 33795572 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of ATX-101 as a treatment for submental fullness: A retrospective analysis of two aesthetic practices. Zarbafian M; Karavan M; Greene R; Fabi SG J Cosmet Dermatol; 2020 Jun; 19(6):1328-1332. PubMed ID: 31553141 [TBL] [Abstract][Full Text] [Related]
17. Deoxycholic Acid: A Review in Submental Fat Contouring. Deeks ED Am J Clin Dermatol; 2016 Dec; 17(6):701-707. PubMed ID: 27785706 [TBL] [Abstract][Full Text] [Related]
18. Real-World Experience With 100 Consecutive Patients Undergoing Neck Contouring With ATX-101 (Deoxycholic Acid): An Updated Report With A 2-Year Analysis. Shridharani SM Dermatol Surg; 2019 Oct; 45(10):1285-1293. PubMed ID: 30789506 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of ATX-101 by Treatment Session: Pooled Analysis of Data From the Phase 3 REFINE Trials. Dayan SH; Schlessinger J; Beer K; Donofrio LM; Jones DH; Humphrey S; Carruthers J; Lizzul PF; Gross TM; Beddingfield FC; Somogyi C Aesthet Surg J; 2018 Aug; 38(9):998-1010. PubMed ID: 29401213 [TBL] [Abstract][Full Text] [Related]
20. ATX-101 for reduction of submental fat: A phase III randomized controlled trial. Humphrey S; Sykes J; Kantor J; Bertucci V; Walker P; Lee DR; Lizzul PF; Gross TM; Beddingfield FC J Am Acad Dermatol; 2016 Oct; 75(4):788-797.e7. PubMed ID: 27430612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]